Genome Editing/Genome Engineering Market by Technology, Product & Service, Application, End-User and Region - Global Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Rising government funding and increase in the number of genomic projects, especially in the area of rare diseases, and a growing application horizon are all expected to drive the growth of the genome editing/genome engineering market.

Market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases & cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

Based on technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies. CRISPR accounted for the largest share of the genome editing/genome engineering market in 2019. The large share of this segment can be attributed to the ease of use associated with the CRISPR technology and its ability to multiplex.

By end-user, the genome editing/genome engineering market is segmented into pharmaceutical companies, biotechnology companies, and academic & government research institutes. The pharmaceutical companies segment accounted for the largest share of the market. The pharmaceutical companies segment accounted for the largest share of the genome editing/genome engineering market in 2019. This is due to the increasing prevalence of infectious diseases and cancer, which is driving research in the pharma sector for drug development.

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, the rising number of genomic projects, and the presence of a genetically diverse population have supported the region's high growth rate.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

5.1 Introduction

5.2 Market Dynamics: Drivers, Opportunities, and Challenges

5.3 Value Chain Analysis

5.4 Impact of Covid-19 Outbreak on the Genome Editing/Genome Engineering Market

6 Genome Editing/Genome Engineering Market, by Technology

6.1 Introduction

6.2 CRISPR

6.3 Talen

6.4 ZFN

6.5 Antisense

6.6 Other Technologies

7 Genome Editing/Genome Engineering Market, by Application

7.1 Introduction

7.2 Cell Line Engineering

7.3 Genetic Engineering

7.4 Diagnostic Applications

7.5 Drug Discovery & Development

7.6 Other Applications

8 Genome Editing/Genome Engineering Market, by Product & Service

8.1 Introduction

8.2 Reagents & Consumables

8.3 Software & Systems

8.4 Services

9 Genome Editing/Genome Engineering Market, by End-user

9.1 Introduction

9.2 Pharmaceutical Companies

9.3 Biotechnology Companies

10 Genome Editing/Genome Engineering Market, by Region

11 Competitive Landscape

11.1 Introduction

11.2 Market Ranking Analysis

11.3 Market Evaluation Framework

11.4 Competitive Leadership Mapping

11.4.1 Visionary Leaders

11.4.2 Dynamic Differentiators

11.4.3 Innovators

11.4.4 Emerging Companies

11.5 Competitive Scenario

11.5.1 Key Product Launches

11.5.2 Key Partnerships & Collaborations

11.5.3 Key Acquisitions

12 Company Profiles

Business Overview, Products and Services Offered, Recent Developments, the Author's View

12.1 Thermo Fisher Scientific

12.2 Merck

12.3 Horizon Discovery

12.4 Genscript

12.5 Sangamo Therapeutics

12.6 Lonza

12.7 Editas Medicine

12.8 CRISPR Therapeutics

12.9 Eurofins Scientific

12.10 Precision Biosciences

12.11 Oxford Genetics

12.12 Intellia Therapeutics

12.13 Synthego

12.14 Vigene Biosciences

12.15 Epigenie

12.16 Integrated DNA Technologies

12.17 New England Biolabs

12.18 Origene Technologies

12.19 Transposagen Biopharmaceuticals

12.20 Creative Biogene

For more information about this report visit https://www.researchandmarkets.com/r/depx8e

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.